Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors
A Standard patent application filed on 23 November 1999 credited to Myers, Michael R. ; Maguire, Martin P. ; Spada, Alfred P. ; He, Wei

Details

Application number :

18294  

Application type :

Standard  

Application status :

CEASED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors  

Inventor :

Myers, Michael R. ; Maguire, Martin P. ; Spada, Alfred P. ; He, Wei  

Agent name :

WATERMARK PATENT AND TRADE MARKS ATTORNEYS  

Address for service :

Level 2 302 Burwood Road HAWTHORN VIC 3122  

Filing date :

23 November 1999  

Associated companies :

 

Applicant name :

Aventis Pharmaceuticals Inc.  

Applicant address :

55 Corporate Drive, Bridgewater, New Jersey, 08807 United States Of America  

Old name :

Aventis Pharmaceuticals Products Inc.  

Original Source :

Go  

Same Inventor

• Quinoline and quinoxaline compounds which inhibit platelet-derived...